title: Practical management of anticoagulation in patients with atrial fibrillation.
abstract: Anticoagulation for atrial fibrillation has become more complex due to the introduction of new anticoagulant agents, the number and kinds of patients requiring therapy, and the interactions of those patients in the matrix of care. The management of anticoagulation has become a "team sport" involving multiple specialties in multiple sites of care. The American College of Cardiology, through the College's Anticoagulation Initiative, convened a roundtable of experts from multiple specialties to discuss topics important to the management of patients requiring anticoagulation and to make expert recommendations on issues such as the initiation and interruption of anticoagulation, quality of anticoagulation care, management of major and minor bleeding, and treatment of special populations. The attendees continued to work toward consensus on these topics, and present the key findings of this roundtable in a state-of- the-art review focusing on the practical aspects of anticoagulation care for the patient with atrial fibrillation.
authors.affiliation: Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, Indiana. Electronic address: rikovacs@iu.edu.
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Kovacs
authors.affiliation: Wes and Simone Chair of Cardiovascular Research, University of Missouri School of Medicine, Columbia, Missouri.
authors.forename: Greg C
authors.initials: GC
authors.lastname: Flaker
authors.affiliation: Sanger Heart and Vascular Institute, Carolinas Health Care System, Charlotte, North Carolina.
authors.forename: Sherry J
authors.initials: SJ
authors.lastname: Saxonhouse
authors.affiliation: Jefferson Heart Institute, Thomas Jefferson University, Philadelphia, Pennsylvania.
authors.forename: John U
authors.initials: JU
authors.lastname: Doherty
authors.affiliation: University of Houston College of Pharmacy, Houston, Texas.
authors.forename: Kim K
authors.initials: KK
authors.lastname: Birtcher
authors.affiliation: Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
authors.forename: Adam
authors.initials: A
authors.lastname: Cuker
authors.affiliation: Division of Pulmonary and Critical Care Medicine, University of Washington School of Medicine, Seattle, Washington.
authors.forename: Bruce L
authors.initials: BL
authors.lastname: Davidson
authors.affiliation: Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
authors.forename: Robert P
authors.initials: RP
authors.lastname: Giugliano
authors.affiliation: Cardiac Care Unit, Duke University Medical Center, Durham, North Carolina.
authors.forename: Christopher B
authors.initials: CB
authors.lastname: Granger
authors.affiliation: Rush University Medical Center, Chicago, Illinois.
authors.forename: Amir K
authors.initials: AK
authors.lastname: Jaffer
authors.affiliation: Ohio State University College of Pharmacy, Columbus, Ohio.
authors.forename: Bella H
authors.initials: BH
authors.lastname: Mehta
authors.affiliation: Center for Pharmacoepidemiology and Pharmacoeconomic Research, University of Illinois at Chicago College of Pharmacy/Antithrombosis Center, University of Illinois at Chicago Hospital and Health Sciences System, Chicago, Illinois.
authors.forename: Edith
authors.initials: E
authors.lastname: Nutescu
authors.affiliation: Rush University Medical Center, Chicago, Illinois.
authors.forename: Kim A
authors.initials: KA
authors.lastname: Williams
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D019468:Disease Management; D006801:Humans; D012307:Risk Factors
chemical_list: D000925:Anticoagulants
keywords: anticoagulation; atrial fibrillation; stroke